BAY-184
BAY-184 is a selective and orally active KAT6A and KAT6B inhibitor. BAY-184 inhibits KAT6A/KAT6B activity with an IC50 of 71 nM and 83 nM. respectively BAY-184 inhibits ERα transcriptional activity. BAY-184 inhibits proliferation of diverse breast cancer subtypes, and inhibits tumor growth[1].
Product Specifications
CAS Number
[2520347-03-7]
UNSPSC
12352005
Target
Estrogen Receptor/ERR; Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bay-184.html
Purity
99.00
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(C1=CC2=C(C=C(N(C)C)C=C2)O1)NS(=O)(C3=C(C4=CC=CC=C4)C=CC=C3)=O
Molecular Formula
C23H20N2O4S
Molecular Weight
420.48
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Zea mays Transposable element activator uncharacterized 12 kDa protein
Recombinant Zea mays Transposable element activator uncharacterized 12 kDa protein
